BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15563153)

  • 1. Specific redistribution of cell-penetrating peptides from endosomes to the cytoplasm and nucleus upon laser illumination.
    Maiolo JR; Ottinger EA; Ferrer M
    J Am Chem Soc; 2004 Dec; 126(47):15376-7. PubMed ID: 15563153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
    Chugh A; Eudes F
    FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CPP-protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway.
    Räägel H; Säälik P; Hansen M; Langel U; Pooga M
    J Control Release; 2009 Oct; 139(2):108-17. PubMed ID: 19577599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells.
    Ruozi B; Montanari M; Vighi E; Tosi G; Tombesi A; Battini R; Restani C; Leo E; Forni F; Vandelli MA
    J Liposome Res; 2009; 19(3):241-51. PubMed ID: 19694606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric screening of cell-penetrating peptides for their uptake into embryonic and adult stem cells.
    Manceur A; Wu A; Audet J
    Anal Biochem; 2007 May; 364(1):51-9. PubMed ID: 17379177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells.
    Potocky TB; Menon AK; Gellman SH
    J Biol Chem; 2003 Dec; 278(50):50188-94. PubMed ID: 14517218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides.
    Bidwell GL; Davis AN; Raucher D
    J Control Release; 2009 Apr; 135(1):2-10. PubMed ID: 19095020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell transduction pathways of transportans.
    Padari K; Säälik P; Hansen M; Koppel K; Raid R; Langel U; Pooga M
    Bioconjug Chem; 2005; 16(6):1399-410. PubMed ID: 16287236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics and in vitro imaging study of matrix metalloproteinase-2 targeting activable cell-penetrating peptide].
    Liu M; Guo YM; Wang P; Guo XJ; Yang JL; Wang SC; Duan XY; Xu GP
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):233-9. PubMed ID: 17425865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells.
    Balzeau J; Peterson A; Eyer J
    Int J Pharm; 2012 Feb; 423(1):77-83. PubMed ID: 21575694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape.
    Foerg C; Ziegler U; Fernandez-Carneado J; Giralt E; Rennert R; Beck-Sickinger AG; Merkle HP
    Biochemistry; 2005 Jan; 44(1):72-81. PubMed ID: 15628847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folding of CFTR is predominantly cotranslational.
    Kleizen B; van Vlijmen T; de Jonge HR; Braakman I
    Mol Cell; 2005 Oct; 20(2):277-87. PubMed ID: 16246729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of fullerene substituted phenylalanine amino acid as a passport for peptides through cell membranes.
    Yang J; Wang K; Driver J; Yang J; Barron AR
    Org Biomol Chem; 2007 Jan; 5(2):260-6. PubMed ID: 17205169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide.
    Sugita T; Yoshikawa T; Mukai Y; Yamanada N; Imai S; Nagano K; Yoshida Y; Shibata H; Yoshioka Y; Nakagawa S; Kamada H; Tsunoda S; Tsutsumi Y
    Biochem Biophys Res Commun; 2007 Nov; 363(4):1027-32. PubMed ID: 17923117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine-rich cell penetrating peptides: from endosomal uptake to nuclear delivery.
    Melikov K; Chernomordik LV
    Cell Mol Life Sci; 2005 Dec; 62(23):2739-49. PubMed ID: 16231085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
    Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R
    J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the endosomal escape of cell-penetrating peptides using a transmembrane pH gradient.
    Madani F; Abdo R; Lindberg S; Hirose H; Futaki S; Langel U; Gräslund A
    Biochim Biophys Acta; 2013 Apr; 1828(4):1198-204. PubMed ID: 23261392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells.
    Albarran B; To R; Stayton PS
    Protein Eng Des Sel; 2005 Mar; 18(3):147-52. PubMed ID: 15820981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
    Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
    Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.